|
End-of-day quote
Korea S.E.
2026-10-23
|
5-day change | 1st Jan Change | ||
| 9,700.00 KRW | -3.39% |
|
+5.09% | +42.23% |
| Dec. 09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 25-06-12 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.39% | +5.09% | +18.58% | +90.94% | +42.23% | +33.24% | - | - | - | 173M | |
| -1.07% | +1.20% | +9.90% | -13.24% | +17.78% | +14.09% | +35.52% | +6.80% | +6.22% | 120B | |
| +0.37% | +2.22% | +10.76% | +22.72% | +0.46% | +4.92% | +103.82% | +85.31% | +473.95% | 102B | |
| +0.64% | +2.67% | -1.18% | +54.19% | +76.33% | +109.83% | +890.32% | +251.47% | +3,959.80% | 58.23B | |
| +1.75% | +2.27% | +0.80% | +5.25% | -5.88% | -5.92% | +83.08% | +12.40% | -34.56% | 29.08B | |
| -0.57% | +2.93% | +2.24% | +6.16% | +39.39% | +32.78% | +95.74% | +65.12% | +189.10% | 26.61B | |
| -0.30% | +3.46% | +6.47% | +10.84% | +31.12% | +17.70% | +65.59% | +16.59% | +135.52% | 26.68B | |
| -0.81% | +0.45% | +7.58% | +15.12% | +35.09% | +27.60% | +378.95% | +280.08% | +1,026.99% | 21.62B | |
| +0.19% | -5.09% | -5.52% | -5.30% | -18.02% | -23.16% | -9.18% | +21.93% | - | 19.58B | |
| -0.68% | +2.72% | +16.15% | +31.01% | +7.68% | +3.48% | +85.69% | -28.17% | - | 18.93B | |
| -1.13% | -1.25% | -1.99% | -4.82% | -9.71% | -5.16% | +33.67% | +19.70% | +22.67% | 17.09B | |
| -1.23% | -1.25% | +7.30% | -17.56% | +60.51% | +79.27% | - | - | - | 12.53B | |
| -1.52% | -2.96% | +1.70% | +9.92% | +16.91% | -1.62% | +98.54% | +75.64% | +210.30% | 12.24B | |
| +3.27% | +2.33% | +2.82% | -6.49% | -0.74% | -14.08% | +23.62% | -33.95% | -46.75% | 12.01B | |
| -1.32% | -1.96% | +5.14% | -22.00% | +61.64% | +42.15% | +126.41% | +58.84% | +216.08% | 11.71B | |
| +1.65% | -2.03% | -13.03% | -12.21% | +9.76% | -1.37% | +55.55% | +91.89% | +484.06% | 11.71B | |
| +2.13% | +4.36% | +2.91% | -3.78% | -25.87% | -33.39% | -51.32% | -70.56% | +99.53% | 11.31B | |
| -0.66% | +0.97% | +5.59% | +19.99% | -14.28% | -11.29% | +50.08% | +37.80% | +50.21% | 11.01B | |
| -1.55% | -0.59% | +1.33% | +1.50% | +0.80% | -5.62% | +81.58% | +143.37% | +804.64% | 10.15B | |
| -0.51% | +1.57% | -3.00% | +2.65% | +0.52% | -1.52% | -27.48% | -17.45% | -10.60% | 9.13B | |
| Average | -0.23% | +0.44% | +3.73% | +9.24% | +16.29% | +13.10% | +117.79% | +56.49% | +474.20% | 27.04B | |
| Weighted average by Cap. | -0.12% | +1.19% | +5.41% | +9.00% | +18.62% | +19.57% | +166.09% | +68.42% | +673.17% |
- Stock Market
- Stocks
- A340450 Stock
- Sector GC Genome Corporation
Select your edition
All financial news and data tailored to specific country editions
